Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Women with PCOS have altered brain structure and reduced cognitive performance.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

National data helps improve palliative care by highlighting and addressing inequalities.

Polygonum multiflorum shows promise for treating Alzheimer's and cognitive impairments.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

PEGylated flavonoid Aspasomes improve brain protection and memory in stress-related disorders.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Different treatments are effective for hair loss conditions, but results vary by individual factors.

Finasteride use is linked to increased reports of cognitive problems, especially in younger people with hair loss.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.